ReviewClinical and experimental medicine2025

From symptom scales to regulatory endpoints: the evolution and clinical impact of patient-reported outcome measures in myeloproliferative neoplasms.

Meng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.